Vabysmo to treat macular degeneration and diabetic macular edema
Drug Name: Vabysmo Indications: To treat neovascular (wet) aged-related macular degeneration and diabetic macular edema. Active Ingredient: Faricimab-svoa Company: Genentech, Inc Approval Date: 1/28/2022 More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761235s000lbl.pdf